Higher drug exposure during the first 24 weeks of ustekinumab treatment is associated with endoscopic remission in Crohn ’s disease
Source: Clinical Gastroenterology and Hepatology - Category: Gastroenterology Authors: Nathalie Van den Berghe, Bram Verstockt, S éverine Vermeire, Debby Thomas, Paul Declerck Source Type: research